- call +1-201-465-4211
- email sales@mrinsights.biz
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
Scope of the Report:
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
China is the largest supplier of Brucellosis Vaccines, with a production market share nearly 31% in 2016. Europe is the second largest supplier of Brucellosis Vaccines, enjoying production market share nearly 17% in 2016.
China is the largest consumption place, with a consumption market share nearly 31% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 17%.
The worldwide market for Brucellosis Vaccines is expected to grow at a CAGR of roughly 3.8% over the next five years, will reach 12 million US$ in 2024, from 10 million US$ in 2019, according to a new study.
This report focuses on the Brucellosis Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
S19 Vaccine
RB51 Vaccine Strain
Other
Market Segment by Applications, can be divided into
Cattle
Sheep
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Brucellosis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brucellosis Vaccines, with price, sales, revenue and global market share of Brucellosis Vaccines in 2017 and 2018.
Chapter 3, the Brucellosis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brucellosis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Brucellosis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Brucellosis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Brucellosis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 S19 Vaccine
1.2.2 RB51 Vaccine Strain
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Cattle
1.3.2 Sheep
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jinyu
2.1.1 Business Overview
2.1.2 Brucellosis Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jinyu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Colorado Serum
2.2.1 Business Overview
2.2.2 Brucellosis Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Brucellosis Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biogenesis-Bago
2.4.1 Business Overview
2.4.2 Brucellosis Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Vetal Company
2.5.1 Business Overview
2.5.2 Brucellosis Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Vetal Company Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 CZ Veterinaria
2.6.1 Business Overview
2.6.2 Brucellosis Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 SYVA Laboratorios
2.7.1 Business Overview
2.7.2 Brucellosis Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Indian Immunologicals
2.8.1 Business Overview
2.8.2 Brucellosis Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Qilu
2.9.1 Business Overview
2.9.2 Brucellosis Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Qilu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tecnovax
2.10.1 Business Overview
2.10.2 Brucellosis Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tecnovax Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hester Biosciences
2.11.1 Business Overview
2.11.2 Brucellosis Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Zoetis
2.12.1 Business Overview
2.12.2 Brucellosis Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zoetis Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Onderstepoort Biological
2.13.1 Business Overview
2.13.2 Brucellosis Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Instituto Rosenbusch
2.14.1 Business Overview
2.14.2 Brucellosis Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Ceva Sante Animale
2.15.1 Business Overview
2.15.2 Brucellosis Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Calier & Biologicos Laverlam
2.16.1 Business Overview
2.16.2 Brucellosis Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Biovet
2.17.1 Business Overview
2.17.2 Brucellosis Vaccines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Biovet Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Brucellosis Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Brucellosis Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Brucellosis Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Brucellosis Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Brucellosis Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Brucellosis Vaccines Market Analysis by Regions
4.1 Global Brucellosis Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Brucellosis Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Brucellosis Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Brucellosis Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Brucellosis Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Brucellosis Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Brucellosis Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Brucellosis Vaccines Sales and Growth Rate (2014-2019)
5 North America Brucellosis Vaccines by Country
5.1 North America Brucellosis Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Brucellosis Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Brucellosis Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Brucellosis Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Brucellosis Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Brucellosis Vaccines Sales and Growth Rate (2014-2019)
6 Europe Brucellosis Vaccines by Country
6.1 Europe Brucellosis Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Brucellosis Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Brucellosis Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Brucellosis Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Brucellosis Vaccines Sales and Growth Rate (2014-2019)
6.4 France Brucellosis Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Brucellosis Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Brucellosis Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Brucellosis Vaccines by Country
7.1 Asia-Pacific Brucellosis Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Brucellosis Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Brucellosis Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Brucellosis Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Brucellosis Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Brucellosis Vaccines Sales and Growth Rate (2014-2019)
7.5 India Brucellosis Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Brucellosis Vaccines Sales and Growth Rate (2014-2019)
8 South America Brucellosis Vaccines by Country
8.1 South America Brucellosis Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Brucellosis Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Brucellosis Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Brucellosis Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Brucellosis Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Brucellosis Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Brucellosis Vaccines by Countries
9.1 Middle East and Africa Brucellosis Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Brucellosis Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Brucellosis Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Brucellosis Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Brucellosis Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Brucellosis Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Brucellosis Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Brucellosis Vaccines Sales and Growth Rate (2014-2019)
10 Global Brucellosis Vaccines Market Segment by Type
10.1 Global Brucellosis Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Brucellosis Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2014-2019)
10.2 S19 Vaccine Sales Growth and Price
10.2.1 Global S19 Vaccine Sales Growth (2014-2019)
10.2.2 Global S19 Vaccine Price (2014-2019)
10.3 RB51 Vaccine Strain Sales Growth and Price
10.3.1 Global RB51 Vaccine Strain Sales Growth (2014-2019)
10.3.2 Global RB51 Vaccine Strain Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Brucellosis Vaccines Market Segment by Application
11.1 Global Brucellosis Vaccines Sales Market Share by Application (2014-2019)
11.2 Cattle Sales Growth (2014-2019)
11.3 Sheep Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Brucellosis Vaccines Market Forecast (2019-2024)
12.1 Global Brucellosis Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Brucellosis Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Brucellosis Vaccines Market Forecast (2019-2024)
12.2.2 Europe Brucellosis Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Brucellosis Vaccines Market Forecast (2019-2024)
12.2.4 South America Brucellosis Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Brucellosis Vaccines Market Forecast (2019-2024)
12.3 Brucellosis Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Brucellosis Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Brucellosis Vaccines Market Share Forecast by Type (2019-2024)
12.4 Brucellosis Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Brucellosis Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Brucellosis Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Brucellosis Vaccines Picture
Table Product Specifications of Brucellosis Vaccines
Figure Global Sales Market Share of Brucellosis Vaccines by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
